Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trialRichard B. Warren, Jóhann E. Guðjónsson, Adam Reich et al.|British Journal of Dermatology|2023Cited by 57
Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1Adam Reich, Jacek C. Szepietowski, Zygmunt Adamski et al.|Dermatology Review|2020Cited by 23
Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 2Adam Reich, Jacek C. Szepietowski, Zygmunt Adamski et al.|Dermatology Review|2020Cited by 21
Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part I: Mild psoriasisAdam Reich, Jacek C. Szepietowski, Zygmunt Adamski et al.|Dermatology Review|2018Cited by 19